A prior section 280b–1, act July 1, 1944, ch. 373, title III, § 392, as added Pub. L. 99–649, § 3,
Another prior section 280b–1, act July 1, 1944, ch. 373, title III, § 391, as added
2025—Subsec. (a)(2)(C). Pub. L. 119–44, § 103(a)(1)(A), inserted “and associated risks” before period at end.
Subsec. (a)(2)(D). Pub. L. 119–44, § 103(a)(1)(B), substituted “substances causing overdose” for “opioids”.
Subsec. (a)(3). Pub. L. 119–44, § 103(b)(1), substituted “and Indian Tribes for the following purposes:” for “and Indian Tribes—” in introductory provisions.
Subsec. (a)(3)(A). Pub. L. 119–44, § 103(b)(2), amended subpar. (A) generally. Prior to amendment, subpar. (A) read as follows: “to carry out innovative projects for grantees to rapidly respond to controlled substance misuse, abuse, and overdoses, including changes in patterns of controlled substance use; and”.
Subsec. (a)(3)(B). Pub. L. 119–44, § 103(b)(3), substituted “For any” for “for any”.
Subsec. (b)(2)(B). Pub. L. 119–44, § 103(a)(2)(A), inserted “, and associated risk factors,” after “such overdoses”.
Subsec. (b)(2)(C). Pub. L. 119–44, § 103(a)(2)(B), substituted “monitoring and identifying” for “coding”.
Subsec. (b)(2)(E). Pub. L. 119–44, § 103(a)(2)(C), inserted a comma after “public health laboratories” and “and other emerging substances related” after “analogues”.
Subsec. (b)(2)(F). Pub. L. 119–44, § 103(a)(2)(D), inserted “and associated risk factors” after “overdoses”.
Subsec. (e). Pub. L. 119–44, § 103(c), substituted “$505,579,000 for each of fiscal years 2026 through 2030” for “$496,000,000 for each of fiscal years 2019 through 2023”.
2022—Subsecs. (a)(1)(B), (C), (b)(1)(B), (C). Pub. L. 117–328, § 1271(b)(2), substituted “Indian Tribes” for “Indian tribes”.
Subsecs. (c) to (e). Pub. L. 117–328, § 1271(b)(1), added subsec. (c) and redesignated former subsecs. (c) and (d) as (d) and (e), respectively.